Health Catalyst files Form 144 to sell 34,485 shares

Health Catalyst, Inc. filed a Form 144 notice for the proposed sale of 34,485 shares of Common Stock on 06/10/2026.

Rhea-AI Filing Summary

Health Catalyst, Inc. filed a Form 144 notice for the proposed sale of 34,485 shares of Common Stock on 06/10/2026. The filing lists the securities as Restricted Stock tied to Compensation.

The record shows prior restricted‑stock sales by the same holder during the past three months: 310 shares on 05/01/2026, 70,455 shares on 03/10/2026, and 336 shares on 06/01/2026, with numeric sale entries shown alongside each date.

Insights

Securities Counsel

Form 144 notifies the market of an intended Rule 144 sale of restricted shares.

Form 144 is a statutory notice used to report proposed sales under Rule 144. The filing here lists 34,485 shares of Common Stock as restricted and identifies compensation as the source, with an intended sale date of 06/10/2026.

The filing also records prior restricted‑stock transfers in the past three months on 05/01/2026, 03/10/2026, and 06/01/2026. The exact cash‑flow treatment and whether sales will occur under Rule 144 conditions are not specified in the excerpt.

Key Figures

Proposed sale: 34,485 shares Broker / Agent reference: Morgan Stanley Smith Barney LLC Prior restricted‑stock sale (May): 310 shares +3 more

6 metrics

Proposed sale 34,485 shares Common Stock; intended sale date 06/10/2026

Broker / Agent reference Morgan Stanley Smith Barney LLC Listed on cover with New York address

Prior restricted‑stock sale (May) 310 shares Sale date 05/01/2026; numeric entry 416.95 shown in row

Prior restricted‑stock sale (March) 70,455 shares Sale date 03/10/2026; numeric entry 130,207.89 shown in row

Prior restricted‑stock sale (June) 336 shares Sale date 06/01/2026; numeric entry 460.39 shown in row

Filing form Form 144 Notice of proposed sale under Rule 144

Key Terms

Form 144, Restricted Stock, Rule 144, Compensation

4 terms

Form 144 regulatory

"Filed notice for proposed sale of restricted shares"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock financial

"Securities classified as Restricted Stock tied to Compensation"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Rule 144 regulatory

"Statutory resale framework for restricted/controlled securities"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Compensation financial

"Source of the restricted shares being sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Health Catalyst's (HCAT) Form 144 report?

It reports a proposed sale of 34,485 shares of Common Stock on 06/10/2026. The filing lists these shares as Restricted Stock and ties them to Compensation.

Who is the selling holder named in the Form 144 for HCAT?

The filing identifies a holder at the address for Benjamin Albert and Morgan Stanley Smith Barney LLC as the broker. The notice lists transactions associated with that holder and the broker on the cover.

What recent restricted‑stock sales are shown in the filing?

The form records restricted stock transfers of 310 shares on 05/01/2026, 70,455 shares on 03/10/2026, and 336 shares on 06/01/2026, each shown with accompanying numeric entries.

Does the Form 144 say Health Catalyst receives proceeds from these sales?

The excerpt classifies the shares as tied to Compensation; it does not state whether the issuer receives proceeds. The filing itself does not specify proceeds treatment in the provided text.

When is the proposed sale effective under the Form 144?

The filing lists an intended sale date of 06/10/2026 for the 34,485 shares of Common Stock categorized as Restricted Stock and tied to Compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 05:11 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002086403
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Health Catalyst, Inc.
SEC File Number	001-38993
Address of Issuer	10897 S River Front Pkwy #300 South Jordan UTAH 84095
Phone	8553096800
Name of Person for Whose Account the Securities are To Be Sold	Benjamin Albert
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	34485	58341.72	73894020	06/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/10/2026	Restricted Stock	Health Catalyst, Inc.			34485	06/10/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Albert c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	05/01/2026	310	416.95
Benjamin Albert c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	03/10/2026	70455	130207.89
Benjamin Albert c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	06/01/2026	336	460.39

144: Remarks and Signature

Remarks
Date of Notice	06/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Benjamin Albert
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)